All Articles

Douglas Herman, who lives with stage IV prostate cancer, highlights the strength that love provides, noting that giving and receiving love are both powerful in their own way. Read More ›

Losing weight and her appetite made Lydia Virgo go to the doctor to get a blood test, which showed a low iron count. Although exhibiting no pain, Lydia’s CT scan and colonoscopy revealed a tumor in her colon. Read More ›

In October 2021, the FDA approved the combination of Verzenio (abemaciclib), a CDK 4/6 inhibitor, plus endocrine therapy for adjuvant treatment (after surgery) of adults with HR-positive, HER2-negative, node-positive, early breast cancer that is at high risk of recurrence. Read More ›

Six months before he was diagnosed with stage IIIB colorectal cancer, both of Joe Bullock’s parents passed away. Chemotherapy hit him hard and stirred a mixture of depression and feelings of inadequacy as a husband and father. Then he discovered the power of opening up. Read More ›

Dr. Maurie Markman explains that missing multiple doctors’ appointments because of the COVID-19 pandemic could have a profound impact on people’s health, because of delayed diagnosis and treatment of cancer. Read More ›

Douglas Herman, who has been diagnosed with stage IV prostate cancer, describes his beautiful painting of the Superstitions Mountains east of Phoenix, Arizona, which symbolizes the link between man and nature and paying tribute to his mom, who passed away from melanoma, and whose ashes were scattered there. Read More ›

A decade after his son passed away from a rare form of bone cancer at age 16, Mark DeLong was diagnosed with prostate cancer. He learned, among other things, the healing power of being vulnerable and sharing personal stories. Read More ›

On November 22, 2021, the FDA approved Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound); from Aadi Bioscience) for adults with locally advanced, unresectable or metastatic malignant perivascular epithelioid-cell tumor (PEComa), a rare type of mesenchymal tumors that can occur in any part of the body.

Read More ›

On August 17, 2021, the FDA accelerated the approval of Jemperli (dostarlimab-gxly; from GlaxoSmithKline) injection, an immunotherapy and a PD-1 inhibitor, for the treatment of all adults with recurrent (coming back) or advanced mismatch repair-deficient (dMMR) solid tumors, including lung cancer, that progressed during or after systemic therapy and for whom there are no satisfactory alternative treatment options. Read More ›

Although we are entering another winter with the ongoing prevalence of the coronavirus, we have come a long way since the initial outbreak. Here are some reasons for patients to be optimistic for the season. Read More ›